Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals
- 1 August 2007
- journal article
- other
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 66 (8) , 1085-1092
- https://doi.org/10.1136/ard.2006.061309
Abstract
Objectives: In vitro, microparticles can activate complement via the classical pathway. If demonstrable ex vivo, this mechanism may contribute to the pathogenesis of rheumatoid arthritis (RA). We therefore investigated the presence of activated complement components and complement activator molecules on the surface of cell-derived microparticles of RA patients and healthy individuals. Methods: Microparticles from synovial fluid (n = 8) and plasma (n = 9) of 10 RA patients and plasma of sex- and age-matched healthy individuals (n = 10) were analysed by flow cytometry for bound complement components (C1q, C4, C3) and complement activator molecules (C-reactive protein (CRP), serum amyloid P component (SAP), immunoglobulin (Ig) M, IgG). Results: Microparticles with bound C1q, C4, and/or C3 were abundant in RA synovial fluid, while in RA and control plasma much lower levels were present. Microparticles with bound C1q correlated with those with bound C3 in synovial fluid (r = 0.961, p = 0.0001), and with those with bound C4 in plasma (RA: r = 0.908, p = 0.0007; control: r = 0.632, p = 0.0498), indicating classical pathway activation. In synovial fluid, microparticles with IgM and IgG correlated with those with C1q (r = 0.728, p = 0.0408; r = 0.952, p = 0.0003, respectively), and in plasma, microparticles with CRP correlated with those with C1q (RA: r = 0.903, p = 0.0021; control: r = 0.683, p = 0.0296), implicating IgG and IgM in the classical pathway activation in RA synovial fluid, and CRP in the low level classical pathway activation in plasma. Conclusions: This study demonstrates the presence of bound complement components and activator molecules on microparticles ex vivo, and supports their role in low grade complement activation in plasma and increased complement activation in RA synovial fluid.Keywords
This publication has 48 references indexed in Scilit:
- The phospholipid composition and cholesterol content of platelet-derived microparticles: a comparison with platelet membrane fractionsJournal of Thrombosis and Haemostasis, 2005
- Microparticles as regulators of inflammation: Novel players of cellular crosstalk in the rheumatic diseasesArthritis & Rheumatism, 2005
- Complement activation by necrotic cells in normal plasma environment compares to that by late apoptotic cells and involves predominantly IgMEuropean Journal of Immunology, 2004
- Cell‐derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII–dependent mechanismArthritis & Rheumatism, 2002
- I-PLA2 Activation during Apoptosis Promotes the Exposure of Membrane Lysophosphatidylcholine Leading to Binding by Natural Immunoglobulin M Antibodies and Complement ActivationThe Journal of Experimental Medicine, 2002
- Direct binding of C1q to apoptotic cells and cell blebs induces complement activationEuropean Journal of Immunology, 2002
- Complement binding is an early feature of necrotic and a rather late event during apoptotic cell deathCell Death & Differentiation, 2001
- Enhancement of macrophage phagocytosis upon iC3b deposition on apoptotic cellsFEBS Letters, 1996
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- C3 PROACTIVATOR CONVERTASE AND ITS MODE OF ACTIONThe Journal of Experimental Medicine, 1972